Amélien Sanlaville
- Immunology top 5%
- T-cell and B-cell Immunology 5
- Immunotherapy and Immune Responses 3
- Immune Cell Function and Interaction 3
- Immune Response and Inflammation 1
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 1
-
- Cancer Genomics and Diagnostics 1
- Breast Cancer Treatment Studies 1
-
- Cell Adhesion Molecules Research 1
- Co-authors
- Christophe CauxJacqueline MarvelJulien C. MarieMark J. SmythSophie DegouveThierry WalzerJacques BienvenuSophia Djebali
- Cited by
- ImmunologyOncologyCancer Research
- Journals
- Nature Communications (2 papers)Cancer Research (1 paper)European Journal of Immunology (1 paper)
- Partner nations
- FranceUnited StatesAustralia
In The Last Decade
Amélien Sanlaville
6 papers receiving 857 citations
Hit Papers
Peers
Comparison fields: 5 of 69
- Immunology 619
- Oncology 409
- Cancer Research 108
- Hematology 44
- Molecular Biology 218
Countries citing papers authored by Amélien Sanlaville
This map shows the geographic impact of Amélien Sanlaville's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amélien Sanlaville with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amélien Sanlaville more than expected).
Fields of papers citing papers by Amélien Sanlaville
This network shows the impact of papers produced by Amélien Sanlaville. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amélien Sanlaville. The network helps show where Amélien Sanlaville may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Amélien Sanlaville, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 105 | |
| 2 | 2021 | 38 | |
| 3 | 2020 | 68 | |
| 4 | TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathwaybreakdown → | 2016 | 493 |
| 5 | 2015 | 8 | |
| 6 | 2013 | 156 |
About Amélien Sanlaville
Amélien Sanlaville is a scholar working on Immunology, Immunology and Allergy and Oncology, having authored 6 papers that have together received 868 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (5 papers), Immunotherapy and Immune Responses (3 papers), Immune Cell Function and Interaction (3 papers), Cancer Genomics and Diagnostics (1 paper), Cell Adhesion Molecules Research (1 paper), Breast Cancer Treatment Studies (1 paper), Immune Response and Inflammation (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Immunology (619 citations), Oncology (409 citations) and Cancer Research (108 citations). Amélien Sanlaville has collaborated with scholars based in France, United States and Australia. Frequent co-authors include Christophe Caux, Jacqueline Marvel, Julien C. Marie, Mark J. Smyth, Sophie Degouve, Thierry Walzer, Jacques Bienvenu, Sophia Djebali, Fernando Guimarães and David K. Finlay. Their work appears in journals such as Nature Communications, Cancer Research and European Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.